Hanil Chemical Ind Past Earnings Performance
Past criteria checks 0/6
Hanil Chemical Ind's earnings have been declining at an average annual rate of -15.8%, while the Chemicals industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 5.9% per year.
Key information
-15.8%
Earnings growth rate
-15.4%
EPS growth rate
Chemicals Industry Growth | 13.9% |
Revenue growth rate | 5.9% |
Return on equity | -10.3% |
Net Margin | -8.9% |
Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How Hanil Chemical Ind makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 116,551 | -10,383 | 10,324 | 809 |
31 Mar 24 | 116,972 | -12,488 | 10,246 | 809 |
31 Dec 23 | 121,936 | -12,206 | 9,918 | 845 |
30 Sep 23 | 128,342 | -9,039 | 10,664 | 591 |
30 Jun 23 | 139,239 | -4,182 | 10,475 | 591 |
31 Mar 23 | 151,474 | 1,854 | 9,677 | 816 |
31 Dec 22 | 155,561 | 5,154 | 10,168 | 777 |
30 Sep 22 | 151,637 | 27,792 | 12,757 | 847 |
30 Jun 22 | 140,538 | 25,640 | 11,065 | 847 |
31 Mar 22 | 125,836 | 23,209 | 10,049 | 785 |
31 Dec 21 | 113,928 | 22,694 | 9,004 | 703 |
30 Sep 21 | 108,782 | 2,843 | 4,837 | 596 |
30 Jun 21 | 102,547 | 2,429 | 4,712 | 596 |
31 Mar 21 | 90,139 | -615 | 4,230 | 576 |
31 Dec 20 | 86,793 | -1,312 | 5,872 | 568 |
30 Sep 20 | 84,073 | -2,336 | 6,171 | 597 |
30 Jun 20 | 87,817 | -1,909 | 6,177 | 597 |
31 Mar 20 | 100,658 | 1,448 | 6,585 | 594 |
31 Dec 19 | 108,720 | 1,669 | 4,563 | 565 |
30 Sep 19 | 118,191 | 1,825 | 4,836 | 533 |
30 Jun 19 | 130,126 | 1,900 | 4,752 | 533 |
31 Mar 19 | 144,558 | 2,282 | 4,521 | 565 |
31 Dec 18 | 152,861 | 2,844 | 4,373 | 599 |
30 Sep 18 | 161,349 | 3,160 | 4,242 | 600 |
30 Jun 18 | 169,565 | 3,736 | 4,286 | 600 |
31 Mar 18 | 158,766 | 3,146 | 4,354 | 561 |
31 Dec 17 | 151,880 | 3,340 | 4,409 | 517 |
30 Sep 17 | 152,709 | 6,008 | 4,551 | 509 |
30 Jun 17 | 143,186 | 4,494 | 4,518 | 509 |
31 Mar 17 | 148,619 | 4,549 | 4,509 | 515 |
31 Dec 16 | 146,757 | 3,179 | 4,579 | 511 |
30 Sep 16 | 128,163 | -578 | 4,427 | 531 |
30 Jun 16 | 118,437 | 1,465 | 4,365 | 531 |
31 Mar 16 | 109,490 | 1,128 | 4,405 | 497 |
31 Dec 15 | 107,203 | 1,591 | 4,419 | 482 |
30 Sep 15 | 112,461 | 3,700 | 4,849 | 467 |
30 Jun 15 | 114,631 | 2,659 | 4,793 | 467 |
31 Mar 15 | 111,581 | 2,025 | 4,737 | 458 |
31 Dec 14 | 110,582 | 2,050 | 4,778 | 426 |
30 Sep 14 | 106,935 | 606 | 4,426 | 402 |
30 Jun 14 | 103,737 | 43 | 4,496 | 402 |
31 Mar 14 | 105,356 | 345 | 4,500 | 376 |
31 Dec 13 | 103,566 | 274 | 4,420 | 355 |
30 Sep 13 | 103,064 | 194 | 4,148 | 340 |
Quality Earnings: A007770 is currently unprofitable.
Growing Profit Margin: A007770 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A007770 is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.
Accelerating Growth: Unable to compare A007770's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A007770 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-7.1%).
Return on Equity
High ROE: A007770 has a negative Return on Equity (-10.3%), as it is currently unprofitable.